SAROGLITAZAR MAGNESIUM FOR THE TREATMENT OF CHYLOMICRONEMIA SYNDROME

• 收藏
• 分享

专利权人:

发明人:

JAIN MUKUL R,GIRI SURESH

申请号：

IN201727037734

公开号：

IN201727037734A

申请日:

2017.10.25

申请国别(地区):

IN

年份:

2017

代理人:

摘要：

The present invention relates to the use of Saroglitazar Magnesium of formula (1) for the treatment of or the prevention delay of progression or treatment of a disease or condition which is selected from chylomicronemia syndrome familial chylomicronemia syndrome and Type V hyperlipoproteinemia. The present invention further relates to the use of a pharmaceutical composition comprising Saroglitazar Magnesium for the prevention delay of progression or treatment of a disease or condition which is selected from chylomicronemia syndrome familial chylomicronemia syndrome and Type V hyperlipoproteinemia.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/